Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The trials are expected to complete in the first half of 2026
10.1016/j.bbagen.2013.09.017 10 BriegerK.SchiavoneS.MillerF
Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines
These findings suggested that our peptide exhibited potent functionality within cells as a senolytic drug with selectivity for senescent cells
Scientists first identified it because of its remarkable ability to stimulate tissue repair and wound healing
US$ 24.49
US$ 28.90
US$ 23.30
US$ 22.26
